Nicole Janine Grzymkowski, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28090 Lemoyne Rd, Millbury, OH 43447 Phone: 419-661-3000 |
Mrs. Lisa Ann Neeson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28090 Lemoyne Rd, Millbury, OH 43447 Phone: 419-661-6680 |
Esperanza Gutierrez, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28150 Lemoyne Rd, Millbury, OH 43447 Phone: 419-661-6682 |
Kathleen Anne Bell, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28090 Lemoyne Rd, Millbury, OH 43447 Phone: 419-661-3000 |
Miss Taryn Renae Wicker, M.A CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28090 Lemoyne Rd, Millbury, OH 43447 Phone: 419-661-6660 |
News Archive
Between 2003 and 2004 the employment gap widened between the number of working-age Americans with disabilities who are employed and those workers without disabilities, a new report on Capitol Hill shows.
MiddleBrook Pharmaceuticals, Inc. today announced that it has entered into an agreement with DoctorDirectory.com Inc., the Company's promotion partner for MOXATAG (amoxicillin extended-release) Tablets, 775 mg, to expand its previously announced IncreaseRx® promotion program.
The National Research Council released a report, "Improving Health in the United States: The Role of Health Impact Assessment." The publication states that "good health is determined by more than money spent on the healthcare system. In fact, a growing body of research indicates that living conditions-including such factors as housing quality, exposure to pollution, and access to healthy and affordable foods and safe places to exercise-have a greater effect on health."
According to latest breakthrough in research, a blood test to detect eight common cancers, even before their symptoms begin to appear, may become a reality soon. The study report appears in the latest issue of the journal Science and gives hope for early detection of these deadly diseases when it could still be treated more effectively.
Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved its New Drug Application for Nymalize (nimodipine) oral solution.
› Verified 1 days ago